Jeil Pharma Holdings Inc (KRX: 002620)

Jeil Pharma Holdings Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	33,579	37,039	34,760	28,581	20,183	21,237
Short-Term Investments	14,463	22,092	18,643	18,643	9,778	8,875
Cash & Short-Term Investments	48,042	59,131	53,403	47,224	29,961	30,112
Cash Growth	-30.24%	10.73%	13.08%	57.62%	-0.50%	-32.23%
Accounts Receivable	184,558	178,437	162,403	149,681	162,013	164,474
Other Receivables	15,423	15,743	15,749	15,305	13,588	16,934
Receivables	199,981	194,180	178,152	164,986	175,601	181,408
Inventory	133,690	125,280	113,266	114,243	124,150	96,784
Prepaid Expenses	102.29	370.95	334.14	210.64	189.94	150.12
Other Current Assets	5,859	5,565	7,762	8,481	5,171	5,166
Total Current Assets	387,675	384,527	352,916	335,144	335,074	313,620
Property, Plant & Equipment	224,930	228,862	233,120	212,965	170,479	163,309
Long-Term Investments	87,633	87,116	83,167	79,022	69,996	65,258
Goodwill	44,862	44,862	73,466	151,801	168,815	168,815
Other Intangible Assets	5,282	4,532	3,978	3,781	4,118	4,350
Long-Term Accounts Receivable	-0	-0	-0	-0	-0	0
Long-Term Deferred Tax Assets	5,707	5,449	188.47	1,452	3,457	2,219
Long-Term Deferred Charges	9,276	8,561	5,494	-	-	-
Other Long-Term Assets	115,788	116,087	113,347	108,256	135,456	127,714
Total Assets	881,154	879,997	865,677	892,421	887,395	845,285
Accounts Payable	156,729	154,050	162,967	159,388	149,265	157,545
Accrued Expenses	382.44	289.4	219.46	144.54	170.17	178.1
Short-Term Debt	137,493	195,937	141,247	88,033	130,510	101,604
Current Portion of Long-Term Debt	-	5,800	3,200	6,125	6,125	6,125
Current Portion of Leases	717.25	707.58	692.18	806.97	574.21	764.25
Current Income Taxes Payable	2,078	774.71	1,160	684.79	4,737	5,087
Other Current Liabilities	79,329	55,077	49,019	42,841	35,937	42,525
Total Current Liabilities	376,728	412,636	358,505	298,024	327,317	313,829
Long-Term Debt	11,900	10,500	16,300	18,531	12,368	13,781
Long-Term Leases	999.91	1,198	1,177	1,576	216.45	320.95
Long-Term Deferred Tax Liabilities	37,776	37,618	35,755	37,747	31,826	23,016
Other Long-Term Liabilities	5,152	5,180	31,421	32,672	7,256	7,243
Total Liabilities	444,865	477,811	445,885	392,108	388,111	363,437
Common Stock	7,987	7,987	7,987	7,987	7,987	7,987
Additional Paid-In Capital	198,634	176,522	176,058	176,384	173,990	168,815
Retained Earnings	66,135	79,119	98,245	172,151	175,785	164,620
Treasury Stock	-3,422	-3,422	-3,422	-3,422	-3,422	-3,422
Comprensive Income & Other	59,339	59,256	58,898	58,631	53,112	55,208
Total Common Equity	328,673	319,461	337,765	411,731	407,452	393,208
Minority Interest	107,616	82,725	82,028	88,583	91,832	88,640
Shareholders' Equity	436,289	402,186	419,792	500,314	499,284	481,848
Total Liabilities & Equity	881,154	879,997	865,677	892,421	887,395	845,285
Total Debt	151,110	214,143	162,616	115,072	149,794	122,595
Net Cash (Debt)	-103,068	-155,012	-109,213	-67,848	-119,832	-92,483
Net Cash Per Share	-6714.04	-10097.73	-7114.36	-4419.76	-7806.10	-6024.51
Filing Date Shares Outstanding	15.35	15.35	15.35	15.35	15.35	15.35
Total Common Shares Outstanding	15.35	15.35	15.35	15.35	15.35	15.35
Working Capital	10,947	-28,109	-5,588	37,120	7,757	-208.53
Book Value Per Share	21410.33	20810.28	22002.60	26820.87	26542.15	25614.28
Tangible Book Value	278,528	270,066	260,320	256,148	234,519	220,043
Tangible Book Value Per Share	18143.84	17592.61	16957.74	16685.95	15276.97	14333.98
Land	98,222	98,147	98,120	83,677	63,100	60,269
Buildings	140,779	140,779	140,778	137,880	120,479	119,451
Machinery	108,499	107,539	101,172	84,428	79,522	76,000
Construction In Progress	3,863	3,269	3,851	11,778	7,583	760.76

Source: S&P Capital IQ. Standard template. Financial Sources.